Real-World Evidence on Short-Term Weight Changes Following Methylphenidate Use in Pediatric Population: A Retrospective Study Using Common Data Model

In July 2025, the Food and Drug Administration (FDA) warned of significant weight loss among young children receiving stimulants for attention-deficit hyperactivity disorder. However, real-world evidence on the magnitude and prevalence of stimulant-associated weight loss remains limited. This study evaluated short-term weight changes after methylphenidate initiation among youth aged 3-18 years using the Medical record Observation and Assessment of drug safety Common Data Model (MOA CDM) in…

via https://pubmed.ncbi.nlm.nih.gov/42634126/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1lqZ3NPYysePVKsoyz66mDSgu4veDGJwnUBS47TBQPoOuNZY5J&fc=None&ff=20260831011005&v=2.20.1